Homeopathy in Lymphatic Filariasis: A Narrative Review

Abstract

Lymphatic filariasis (LF) is globally considered a neglected tropical disease (NTD), as well as the second leading cause of disability. The financial and social burden of LF is significant and has an impact on the patient's ability to work, participate in social activities, and raise a family. Diethylcarbamazine (DEC), an antifilarial medication, is currently the preferred treatment for LF. However, its use can have some short-term adverse events. So, the effective management of LF is the need of the hour for preventing disease progression and episodes of acute adenolymphangitis. This article attempts to review the available literature on homeopathic intervention, which is an alternative, cost-effective and safer therapeutic option in the treatment of LF. A comprehensive search was made for studies conducted from 1980 to 2019 in different databases and resources, including PubMed, ScienceDirect, and Google Scholar. In addition, a manual search of monographs and research studies of the Central Council for Research in Homoeopathy (CCRH) related to filariasis was conducted through the AYUSH Research Portal, Archive on Homoeopathy, and CCRH e-library. According to study design, aims and objectives, sample size, study duration, intervention, outcome parameters, and results, the literature that is currently accessible has been categorized. Out of 15 studies screened, 8 related to homeopathy on LF were selected for this review. Of these, 1 randomized open label comparative trial, 2 single-blind nonrandomized placebo-controlled trials, 4 single-arm interventional trials, and 1 retrospective observational study were found. Except one single blind placebo-controlled nonrandomized study, the outcomes of other studies were found to be in favor of homeopathy. The review shows that there may be some beneficial effects of homeopathy in the management of LF. However, there are inconsistencies, gaps in the study, and insufficient outcome measures in the included literatures, which make it impossible to draw any firm conclusions. Subsequent research endeavors ought to surmount these challenges and conform to enhanced research design and methods.

Keywords

lymphatic filariasis - microfilariae - homeopathy - lymphedema - narrative review

Publikationsverlauf

Artikel online veröffentlicht:
30. August 2024

• References

• 1 Centers for Disease Control Prevention (CDC). Prevention. Lymphatic Filariasis: Prevention & Control. 2020. Accessed December 4, 2022 at: https://www.cdc.gov/parasites/lymphaticfilariasis/prevent.html
• 2 World Health Organization (WHO). Lymphatic Filariasis. 2022 . Accessed December 4, 2022 at: https://www.who.int/en/news-room/fact-sheets/detail/lymphatic-filariasis
• 3 Centers for Disease Control and Prevention (CDC). Lymphatic Filariasis: Epidemiology & Risk Factors. 2022 . Accessed November 14, 2022 at: https://www.cdc.gov/parasites/lymphaticfilariasis/index.html
• 4 Zeldenryk LM, Gray M, Speare R, Gordon S, Melrose W. The emerging story of disability associated with lymphatic filariasis: a critical review. PLoS Negl Trop Dis 2011; 5 (12) e1366
• 5 Central Council for Research in Homoeopathy (CCRH). Homoeopathic Therapy in the Management of Lymphatic Filariasis. Disease Monograph-I. New Delhi, India: CCRH; 2010: 89-111
• 6 George S, Joy TM, Kumar A. et al. Prevalence of neglected tropical diseases (leishmaniasis and lymphatic filariasis) and malaria among a migrant labour settlement in Kerala, India. J Immigr Minor Health 2019; 21 (03) 563-569
• 7 Ottesen EA. The Global Programme to Eliminate Lymphatic Filariasis. Trop Med Int Health 2000; 5 (09) 591-594
• 8 Raju K, Jambulingam P, Sabesan S, Vanamail P. Lymphatic filariasis in India: epidemiology and control measures. J Postgrad Med 2010; 56 (03) 232-238
• 9 Addiss DG, Brady MA. Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature. Filaria J 2007; 6: 2
• 10 Tripathi B, Roy N, Dhingra N. Introduction of triple-drug therapy for accelerating lymphatic filariasis elimination in India: lessons learned. Am J Trop Med Hyg 2022; 106 (5_suppl): 29-38
• 11 Gyapong JO, Gyapong M, Adjei S. The epidemiology of acute adenolymphangitis due to lymphatic filariasis in northern Ghana. Am J Trop Med Hyg 1996; 54 (06) 591-595
• 12 Bockarie MJ, Deb RM. Elimination of lymphatic filariasis: do we have the drugs to complete the job?. Curr Opin Infect Dis 2010; 23 (06) 617-620
• 13 Hahnemann S. Organon of Medicine. Combined 5th and 6th ed. Dudgeon RE. and Boericke W. , trans. New Delhi, India:: B Jain Publishers (P) Ltd.;; 2005
• 14 Gupta J, Manchanda RK, Debata LP. et al. A randomised comparative study to evaluate the efficacy of Homoeopathic treatment-vs-standard allopathy treatment for acute adenolymphangitis due to lymphatic filariasis. Indian J Res Homoeopathy 2018; 12: 64-74
• 15 Subramanyam VR, Mishra N, Rai Y, Rakshit G, Pattanaik NM. Homeopathic treatment of filariasis: experience in an Indian rural setting. Br Homeopath J 1990; 79 (03) 157-160
• 16 Kumar A, Mishra N. Effect of homoeopathic treatment on filariasis. A single blind 69-months follow-up study in an endemic village in Orissa. Br Homeopath J 1994; 83: 216-219
• 17 Rudra SK, Sukul NC, Sukul A. Antifilarial effect of two homeopathic potencies against human filariasis. Clin Exp Homeopath. 2009; 1: 2
• 18 Mishra N. Research studies in filaria. CCRH Q Bull. 1998; 20: 22-24
• 19 Rastogi DP, Mishra N. Clinical research in filariasis. CCRH Q Bull. 1991; 13: 1-4
• 20 Nayak C. Clinical study of the effects of homoeopathic medicines in filariasis. Hahnemann Gleanings. 1985; 52: 298-302
• 21 Sahoo PK, Babu Geddam JJ, Satapathy AK. et al. Bancroftian filariasis: a 13-year follow-up study of asymptomatic microfilariae carriers and endemic normals in Orissa, India. Parasitology 2002; 124 (Pt 2): 191-201
• 22 Dhingreja J. A case of chyluria resulting from a chylo-lymphatic malformation of kidney cured with homoeopathic medicine: a case report. Int J Curr Res Rev 2016; 8: 14
• 23 Nwabudike LC, Buzia O, Elisei AM, Tatu AL. An integrative therapeutic approach to elephantiasis nostras verrucosa: a case report. Exp Ther Med 2022; 23 (04) 289
• 24 Mishra N. Disease Monograph-I, Homoeopathic Approach, Lymphatic Filariasis. New Delhi, India:: CCRH; 2010: 112-113
• 25 Central Council for Research in Homoeopathy (CCRH). Determination of bacterial growth in blood samples of patients during acute attack in LF and its homoeopathic management. . In: Disease Monograph-I. New Delhi, India: CCRH; 2010: 118-119
• 26 World Health Organization. WHOQOL-BREF. Geneva: WHO;
• 27 Bornhöft G, Wolf U, von Ammon K. et al. Effectiveness, safety and cost-effectiveness of homeopathy in general practice - summarized health technology assessment. Forsch Komplement Med 2006; 13 (Suppl. 02) 19-29
• 28 Babu BV, Nayak AN. Treatment costs and work time loss due to episodic adenolymphangitis in lymphatic filariasis patients in rural communities of Orissa, India. Trop Med Int Health 2003; 8 (12) 1102-1109
• 29 Sahoo AR, Barik B, Hati AK, Paital B. Right potency matters: a case report of homoeopathic treatment of verruca palmaris. Homoeopath Links 2018; 31: 204-208
• 30 Babu S, Nutman TB. Immunology of lymphatic filariasis. Parasite Immunol 2014; 36 (08) 338-346
• 31 Van 't Noordende AT, Aycheh MW, Moges NA, Tadesse T, Schippers AP. Family-based intervention for prevention and self-management of disabilities due to leprosy, podoconiosis and lymphatic filariasis versus usual care in Ethiopia: study protocol for a cluster-randomised controlled trial. BMJ Open 2022; 12 (03) e056620
• 32 Van't Noordende AT, Wubie Aycheh M, Tadesse T, Hagens T, Haverkort E, Schippers AP. A family-based intervention for prevention and self-management of disabilities due to leprosy, podoconiosis and lymphatic filariasis in Ethiopia: a proof of concept study. PLoS Negl Trop Dis 2021; 15 (02) e0009167